Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
First Affiliated Hospital of Fujian Medical University
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Prostate cancer diagnosed by prostate biopsy and underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' hospital.
Received plain and contrast-enhanced pelvic or prostate MRI examinations before surgery.
Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1.
Complete clinicopathological data.
In good general condition, without infections, autoimmune diseases, hematological diseases or other malignant tumors.
Complete postoperative follow-up data, with a postoperative follow-up time of no less than 6 months.
You may not be if
The patient has surgical contraindications.
The patient has contraindications for MRI examination.
Preoperative presence of congenital urinary system malformations, urinary incontinence or severe lower urinary tract symptoms, and with a history of urinary catheter or previous transurethral resection of the prostate (TURP) surgery.
Having received neoadjuvant treatments that may affect the results of this study, such as radiotherapy or hormonal therapy.
The patient has other concurrent malignant tumors.
The patient has delayed extubation (\> 14 days).
The patient's clinical, imaging and pathological data are incomplete or the patient is lost to follow-up.
Clareo Health | Analysis of Immediate Urinary Continence Predictors After RS-RARP
